Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Long-term follow-up of laryngeal Rhinosporidium seeberi diagnosed by PCR and treated with laser ablation and voriconazole nebulization in a retired thoroughbred polo horse.
Abstract: A 21-year-old retired polo Argentinian thoroughbred horse from a teaching herd was presented for a routine bronchoalveolar lavage demonstration, during which an incidental finding of a granulomatous mass on the dorsal aspect of the epiglottis was made. Rhinosporidium seeberi was suspected from a histological section obtained from an initial biopsy, and the mass was removed via laser surgery for cytology and PCR. Sequencing of the PCR amplicons confirmed the diagnosis of R. seeberi. A treatment protocol of nebulized voriconazole for 10 d postoperatively was used. Long-term follow-up required 2 more laser surgeries plus oral fluconazole to resolve the remaining fungal spores. However, 2.5 y later, there was no evidence of remaining fungal spores. Key clinical message: Horses from endemic regions can potentially be exposed to R. seeberi. Based on its travel history, this horse may have contracted the infection in South America, California, or Alberta. Treatments administered, including diode laser resection, voriconazole antifungal nebulization, and oral fluconazole administration, were successful but required repeated interventions. Suivi à long terme du Rhinosporidium seeberi laryngé diagnostiqué par PCR et traité par ablation au laser et nébulisation au voriconazole chez un cheval de polo thoroughbred pur-sang à la retraiteUn cheval thoroughbred argentin de polo retraité de 21 ans, issu d’un troupeau d’enseignement, a été présenté pour une démonstration de lavage broncho-alvéolaire de routine, au cours de laquelle une découverte fortuite d’une masse granulomateuse sur la face dorsale de l’épiglotte a été faite. Rhinosporidium seeberi a été suspecté à partir d’une coupe histologique obtenue à partir d’une biopsie initiale, et la masse a été retirée par chirurgie au laser pour cytologie et PCR. Le séquençage des amplicons PCR a confirmé le diagnostic de R. seeberi. Un protocole de traitement au voriconazole nébulisé pendant 10 jours après l’opération a été utilisé. Le suivi à long terme a nécessité 2 autres interventions chirurgicales au laser et du fluconazole oral pour éliminer les spores fongiques restantes. Cependant, 2,5 ans plus tard, il n’y avait aucune trace de spores fongiques restantes.Message clinique clé:Les chevaux des régions endémiques peuvent potentiellement être exposés à R. seeberi. D’après ses antécédents de voyage, ce cheval pourrait avoir contracté l’infection en Amérique du Sud, en Californie ou en Alberta. Les traitements administrés, notamment la résection au laser à diode, la nébulisation antifongique au voriconazole et l’administration orale de fluconazole, ont été efficaces mais ont nécessité des interventions répétées.(Traduit par Dr Serge Messier).
Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.
Publication Date: 2024-07-02 PubMed ID: 38952752PubMed Central: PMC11195513 The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Case Reports
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study is about a 21-year-old retired polo horse from Argentina that had a fungal infection identified as Rhinosporidium seeberi in its larynx, treated using laser surgery and the antifungal drug voriconazole. The treatment was successful, however, it required repeated procedures to fully clear the fungal spores.
Identification of Laryngeal Rhinosporidium Seeberi in a Horse
- This research was conducted on a 21-year-old retired polo Argentinian thoroughbred horse that was part of a teaching herd.
- The horse was initially presented for a routine bronchoalveolar lavage demonstration, a medical procedure in which a bronchoscope is passed through the mouth or nose into the lungs to obtain fluid for diagnostic testing.
- During this procedure, a granulomatous mass was unexpectedly discovered on the dorsal aspect of the horse’s epiglottis. The presence of Rhinosporidium seeberi, a type of fungus, was suspected from a histological section obtained from an initial biopsy.
- The mass was removed using laser surgery, and the removed tissue was analysed using cytology and Polymerase Chain Reaction (PCR) processes. This confirmed the presence of Rhinosporidium seeberi.
Treatment of Rhinosporidium Seeberi
- An antifungal treatment protocol was followed postoperatively. This involved the use of nebulized voriconazole, an antifungal medication, for 10 days.
- The long-term follow-up of the horse’s medical condition required two more laser surgeries and oral administration of another antifungal drug, fluconazole, to completely eliminate the remaining fungal spores.
- 2.5 years after initial detection and treatment, there were no traces of remaining fungal spores.
Key Clinical Message
- Horses from regions endemic with Rhinosporidium seeberi can potentially be exposed to this fungus.
- Based on the travel history of the treated horse in this study, it is suggested that it might have contracted the infection in either South America, California, or Alberta.
- The treatments employed, including diode laser resection, voriconazole antifungal nebulization, and oral fluconazole administration, effectively treated the Rhinosporidium seeberi infection but required repeated interventions.
Cite This Article
APA
Toner S, Leguillette R, Israel J, Legge C, Samani ARE, Kavanagh M, Goodmanson M.
(2024).
Long-term follow-up of laryngeal Rhinosporidium seeberi diagnosed by PCR and treated with laser ablation and voriconazole nebulization in a retired thoroughbred polo horse.
Can Vet J, 65(7), 667-674.
Publication
Researcher Affiliations
- Faculty of Veterinary Medicine, University of Calgary, 11877 85th Street NW, Calgary, Alberta T3R 1J3.
- Faculty of Veterinary Medicine, University of Calgary, 11877 85th Street NW, Calgary, Alberta T3R 1J3.
- Faculty of Veterinary Medicine, University of Calgary, 11877 85th Street NW, Calgary, Alberta T3R 1J3.
- Faculty of Veterinary Medicine, University of Calgary, 11877 85th Street NW, Calgary, Alberta T3R 1J3.
- Faculty of Veterinary Medicine, University of Calgary, 11877 85th Street NW, Calgary, Alberta T3R 1J3.
- Faculty of Veterinary Medicine, University of Calgary, 11877 85th Street NW, Calgary, Alberta T3R 1J3.
- Faculty of Veterinary Medicine, University of Calgary, 11877 85th Street NW, Calgary, Alberta T3R 1J3.
MeSH Terms
- Animals
- Horses
- Horse Diseases / drug therapy
- Horse Diseases / surgery
- Horse Diseases / diagnosis
- Voriconazole / therapeutic use
- Voriconazole / administration & dosage
- Antifungal Agents / therapeutic use
- Antifungal Agents / administration & dosage
- Male
- Rhinosporidiosis / veterinary
- Rhinosporidiosis / drug therapy
- Rhinosporidiosis / surgery
- Rhinosporidiosis / diagnosis
- Nebulizers and Vaporizers / veterinary
- Laser Therapy / veterinary
- Polymerase Chain Reaction / veterinary
- Laryngeal Diseases / veterinary
- Laryngeal Diseases / surgery
- Laryngeal Diseases / drug therapy
References
This article includes 29 references
- Fredricks DN, Jolley JA, Lepp PW. A human pathogen from a novel group of aquatic protistan parasitesRhinosporidium seeberi.. Emerg Infect Dis 2000;6:273–282.
- Herr RA, Ajello L, Taylor JW. Phylogenetic analysis of Rhinosporidium seeberi’s 18S small-subunit ribosomal DNA groups this pathogen among members of the Protoctista Mesomycetozoa clade.. J Clin Microbiol 1999;37:2750–2754.
- Leeming G, Smith KC, Bestbier ME. Equine rhinosporidiosis in United Kingdom.. Emerg Infect Dis 2007;13:1377–1379.
- Myers DD, Simon J, Case MT. Rhinosporidiosis in a horse.. J Am Vet Med Assoc 1964;145:345–347.
- Londero AT, Santos MN, Freitas CJ. Animal rhinosporidiosis in Brazil. Report of three additional cases.. Mycopathologia 1977;60:171–173.
- Zschokke E. Ein Rhinosporidium beim Pferd.. Schweiz Arch Tierheilkd 1913;55:641–650.
- Burgess HJ, Lockerbie BP, Czerwinski S, Scott M. Equine laryngeal rhinosporidiosis in western Canada.. J Vet Diagn Invest 2012;24:777–780.
- Hoff B, Hall DA. Rhinosporidiosis in a dog.. Can Vet J 1986;27:231–232.
- Brenseke BM, Saunders GK. Concurrent nasal adenocarcinoma and rhinosporidiosis in a cat.. J Vet Diagn Invest 2010;22:155–157.
- Easley JR, Meuten DJ, Levy MG. Nasal rhinosporidiosis in the dog.. Vet Pathol 1986;23:50–56.
- Kennedy FA, Buggage RR, Ajello L. Rhinosporidiosis: A description of an unprecedented outbreak in captive swans (Cygnus spp.) and a proposal for revision of the ontogenic nomenclature of Rhinosporidium seeberi.. J Med Vet Mycol 1995;33:157–165.
- Leeming G, Hetzel U, Campbell T, Kipar A. Equine rhinosporidiosis: An exotic disease in the UK.. Vet Rec 2007;160:552–554.
- Castellano M, Breitschwerdt E. Rhinosporidiosis.. .
- Harissi-Dagher M, Robillard N, Corriveau C. Histopathologically confirmed ocular rhinosporidiosis in two Canadians.. Can J Ophthalmol 2006;41:226–229.
- Belliveau MJ, Strube YNJ, Dexter DF, Kratky V. Bloody tears from lacrimal sac rhinosporidiosis.. Can J Ophthalmol 2012;47:22–23.
- Arseculeratne SN, Mendoza L. Rhinosporidiosis.. .
- Das S, Kashyap B, Barua M. Nasal rhinosporidiosis in humans: New interpretations and a review of the literature of this enigmatic disease.. Med Mycol 2011;49:311–315.
- Nollet H, Vercauteren G, Martens A. Laryngeal rhinosporidiosis in a Belgian warmblood horse.. Zoonoses Public Health 2008;55:274–278.
- Arseculeratne SN. Recent advances in rhinosporidiosis and Rhinosporidium seeberi.. Indian J Med Microbiol 2002;20:119–131.
- Tizzano MA, Della Vedova R, Lopez RA. Equine rhinosporidiosis in Buenos Aires, Argentina.. Rev Argent Microbiol 2022;54:22–24.
- Gardiner C, Fayer R, Dubey J. An Atlas of Protozoan Parasites in Animal Tissues.. .
- Colitz CM, Latimer FG, Cheng H, Chan KK, Reed SM, Pennick GJ. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.. Am J Vet Res 2007;68:1115–1121.
- Davis JL, Salmon JH, Papich MG. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.. Am J Vet Res 2006;67:1070–1075.
- Passler NH, Chan HM, Stewart AJ. Distribution of voriconazole in seven body fluids of adult horses after repeated oral dosing.. J Vet Pharmacol Ther 2010;33:35–41.
- Sierra-Rodriguez T, Groover ES, Lascola KM. Clinical feasibility and airway deposition of nebulized voriconazole in healthy horses.. J Equine Vet Sci 2020;94:1032–1046.
- Pirie RS, McGorum BC. Inhalation therapy for equine lower respiratory tract disease.. Practitioner 2017;39:317–327.
- Burton A, Giguere S, Arnold R. Pharmacokinetics, pulmonary disposition and tolerability of liposomal gentamicin and free gentamicin in foals.. Equine Vet J 2015;47:467–472.
- Fultz L, Giguere S, Berghaus LJ. Pulmonary pharmacokinetics of desfuroylceftiofur acetamide after nebulisation or intramuscular administration of ceftiofur sodium to weanling foals.. Equine Vet J 2015;47:473–477.
- Latimer FG, Colitz CM, Campbell NB, Papich MG. Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses.. Am J Vet Res 2001;62:1606–1611.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
